Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
European Geriatric Medicine
Erschienen in:

01.06.2019 | Research Paper

Prescription and deprescription of medications for older adults receiving palliative care during the last 3 months of life: a single-center retrospective cohort study

verfasst von: Barbara Roux, Lucas Morin, Arnaud Papon, Marie-Laure Laroche

Erschienen in: European Geriatric Medicine | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Key Summary Points

Aim

To assess the evolution and quality of drug therapy throughout the last 3 months of life of older adults in need of palliative care.

Findings

This study highlights the preferential prescription of essential drugs and deprescription of unnecessary drugs during the last 3 months of life in older adults. However, palliative care occurs principally during the last week of life and a high burden of unnecessary drugs is still found on the day of death.

Message

Both earlier implementation of palliative care and an improvement of prescribing practices are needed by setting up interventions to raise awareness and promote early physician–patient communication about care goals and potential benefits of deprescribing unnecessary drugs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Morin L, Vetrano DL, Rizzuto D, Calderón-Larrañaga A, Fastbom J, Johnell K (2017) Choosing wisely? Measuring the burden of medications in older adults near the end of life: Nationwide, longitudinal cohort study. Am J Med 130(927–936):e9
2.
McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP (2016) The burden of polypharmacy in patients near the end of life. J Pain Symptom Manag 51:178e2–183e2CrossRef
3.
Van Den Noortgate NJ, Verhofstede R, Cohen J, Piers RD, Deliens L, Smets T (2016) Prescription and deprescription of medication during the last 48 hours of life: Multicenter study in 23 acute geriatric wards in Flanders Belgium. J Pain Symptom Manag 51:1020–1026CrossRef
4.
Van Nordennen RT, Lavrijsen JC, Heesterbeek MJ, Vissers KC, Koopmans RT (2016) Changes in prescribed drugs between admission and the end of life in patients admitted to palliative care facilities. J Am Med Dir Assoc 17:514–518CrossRefPubMed
5.
Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ (2006) Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 54:1516–1523CrossRefPubMed
6.
Franken LG, De Winter BC, Van Esch HJ et al (2016) Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol. Expert Opin Drug Metab Toxicol 12:669–680CrossRefPubMed
7.
Todd A, Nazar H, Inga A, Pearson SA, Lindsey L, Holmes H (2017) Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Support Palliat Care 7:113–121CrossRefPubMed
8.
Fede A, Miranda M, Antonangelo D et al (2011) Use of unnecessary medications by patients with advanced cancer: cross-sectional survey. Support Care Cancer 19:1313–1318CrossRefPubMed
9.
Tjia J, Lapane K (2017) Guideline-Based Prescribing in Frail Elderly Patients. JAMA Intern Med 177:262–263CrossRefPubMed
10.
Riechelmann RP, Krzyzanowska MK, Zimmermann C (2009) Futile medication use in terminally ill cancer patients. Support Care Cancer 17:745–748CrossRefPubMed
11.
Lee HR, Yi SY, Kim DY (2013) Evaluation of prescribing medications for terminal cancer patients near death: essential or futile. Cancer Res Treat 45:220–225CrossRefPubMedPubMedCentral
12.
Lindsay J, Dooley M, Martin J et al (2015) The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’. Support Care Cancer 23:71–78CrossRefPubMed
13.
Holmes HM, Sachs GA, Shega JW, Hougham GW, Cox Hayley D, Dale W (2008) Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc 56:1306–1311CrossRefPubMed
14.
Tjia J, Briesacher BA, Peterson D, Liu Q, Andrade SE, Mitchell SL (2014) Use of medications of questionable benefit in advanced dementia. JAMA Intern Med 174:1763CrossRefPubMedPubMedCentral
15.
Morin L, Vetrano DL, Grande G, Fratiglioni L, Fastbom J, Johnell K (2017) Use of medications of questionable benefit during the last year of life of older adults with dementia. J Am Med Dir Assoc 18:551.e1–551.e7CrossRef
16.
Matlow JN, Bronskill SE, Gruneir A et al (2017) Use of medications of questionable benefit at the end of life in nursing home residents with advanced dementia. J Am Geriatr Soc 65:1535–1542CrossRefPubMed
17.
Suhrie EM, Hanlon JT, Jaffe EJ, Sevick MA, Ruby CM, Aspinall SL (2009) Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing. Am J Geriatr Pharmacother 7:20–25CrossRefPubMedPubMedCentral
18.
Lim MY (2009) Audit on the management of diabetes in terminally-ill medical patients. Prog Palliat Care 17:302–306CrossRef
19.
Todd A, Nazar H, Pearson S, Andrew L, Baker L, Husband A (2014) Inappropriate prescribing in patients accessing specialist palliative day care services. Int J Clin Pharm 36:535–543CrossRefPubMed
20.
Barceló M, Torres O, Ruiz D, Casademont J (2014) Appropriateness of medications prescribed to elderly patients with advanced heart failure and limited life expectancy who died during hospitalization. Drugs Aging 31:541–546CrossRefPubMed
21.
Sevilla-Sánchez D, Molist-Brunet N, Amblàs-Novellas J, Espaulella-Panicot J, Codina-Jané C (2017) Potentially inappropriate medication at hospital admission in patients with palliative care needs. Int J Clin Pharm 39:1018–1030CrossRefPubMed
22.
Sevilla-Sánchez D, Molist-Brunet N, Espaulella-Panicot J et al (2018) Potentially inappropriate medication in palliative care patients according to STOPP-Frail criteria. Eur Geriatr Med 9:543–550CrossRefPubMed
23.
Pype P, Mertens F, Helewaut F, D’Hulster B, De Sutter A (2018) Potentially inappropriate medication in primary care at the end of life: a mixed-method study. Acta Clin Belg 73:213–219CrossRefPubMed
24.
Van der Meer HG, Taxis K, Pont LG (2018) Changes in prescribing symptomatic and preventive medications in the last year of life in older nursing home residents. Front Pharmacol 8:990CrossRefPubMedPubMedCentral
25.
Curtin D, O’Mahony D, Gallagher P (2018) Drug consumption and futile medication prescribing in the last year of life: an observational study. Age Ageing 47:749–753CrossRefPubMed
26.
Heppenstall CP, Broad JB, Boyd M et al (2016) Medication use and potentially inappropriate medications in those with limited prognosis living in residential aged care: medication use in residential aged care. Austral J Ageing 35(2):E18–24CrossRef
27.
De Lima L (2007) International association for hospice and palliative care list of essential medicines for palliative care. Ann Oncol 18:395–399CrossRefPubMed
28.
29.
30.
Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM (2007) Prescribing in palliative care as death approaches: Polypharmacy in palliative care. J Am Geriatr Soc 55:590–595CrossRefPubMed
31.
Dwyer LL, Lau DT, Shega JW (2015) Medications that older adults in hospice care in the United States take, 2007. J Am Geriatr Soc 63:2282–2289CrossRefPubMed
32.
Masman AD, van Dijk M, Tibboel D, Baar FP, Mathôt RA (2015) Medication use during end-of-life care in a palliative care centre. Int J Clin Pharm 37:767–775CrossRefPubMedPubMedCentral
33.
Beernaert K, Cohen J, Deliens L et al (2013) Referral to palliative care in COPD and other chronic diseases: a population-based Study. Respir Med 107:1731–1739CrossRefPubMed
34.
Van den Block L, Deschepper R, Bossuyt N et al (2008) Care for patients in the last months of life: the Belgian sentinel network monitoring end-of-Life Care study. Arch Intern Med 168:1747–1754CrossRefPubMed
35.
Murray SA, Kendall M, Mitchell G, Moine S, Amblàs-Novellas J, Boyd K (2017) Palliative care from diagnosis to death. BMJ 356:j878CrossRefPubMed
36.
Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non–small-cell lung cancer. N Engl J Med 363:733–742CrossRefPubMed
37.
World Health Organization (2014) Strengthening of palliative care as a component of integrated treatment throughout the life course. J Pain Palliat Care Pharmacother 28:130–134CrossRef
38.
Reeve E, Gnjidic D, Long J, Hilmer S (2015) A systematic review of the emerging definition of « deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 80:1254–1268CrossRefPubMedPubMedCentral
39.
Kutner JS, Blatchford PJ, Taylor DH Jr et al (2015) Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med 175:691–700CrossRefPubMedPubMedCentral
40.
Lavan AH, Gallagher P, Parsons C, O’Mahony D (2017) STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail Adults with Limited Life Expectancy): consensus validation. Age Ageing 46:600–607CrossRefPubMed
41.
42.
43.
Van Nordennen RT, Lavrijsen JC, Vissers KC, Koopmans RT (2014) Decision making about change of medication for comorbid disease at the end of life: an integrative review. Drugs Aging 31:501–512CrossRefPubMed
44.
Tran QNH (2010) Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer. Am J Hosp Palliat Care 27:416–419CrossRefPubMed
Metadaten
Titel
Prescription and deprescription of medications for older adults receiving palliative care during the last 3 months of life: a single-center retrospective cohort study
verfasst von
Barbara Roux
Lucas Morin
Arnaud Papon
Marie-Laure Laroche
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
European Geriatric Medicine / Ausgabe 3/2019
Elektronische ISSN: 1878-7657
DOI
https://doi.org/10.1007/s41999-019-00175-3

Weitere Artikel der Ausgabe 3/2019

Adding lactate to SOFA and qSOFA scores predicts in-hospital mortality better in older patients in critical care

  • Research Paper

How effective is nutrition education aiming to prevent or treat malnutrition in community-dwelling older adults? A systematic review

  • Review

Does comprehensive geriatric assessment (CGA) in an outpatient care setting affect the causes of death and the quality of palliative care? A subanalysis of the age-FIT study

  • Open Access
  • Research Paper

Care transitions programs for older adults—a worldwide need

  • Special Article

Development of the “chronic condition measurement guide”: a new tool to measure chronic conditions in older people based on ICD-10 and ATC-codes

  • Research Paper

Association of depressive symptoms and subjective memory complaints with the incidence of cognitive impairment in older adults with high blood pressure

  • Research Paper

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Chemoembolisation bei HCC frühzeitig mit Checkpoint-Inhibitor kombinieren?

Beim hepatozellulären Karzinom scheint sich eine neue Therapieoption abzuzeichnen: In zwei randomisierten Studien ließ sich das progressionsfreie Überleben mit der Kombination aus Chemoembolisation, Checkpoint-Inhibitor und antiangiogener Therapie signifikant verbessern. 

Antikörper-Wirkstoff-Konjugat hält Brusttumoren langfristig in Schach

Erreichen Frauen mit HER2-positivem Mammakarzinom nach einer neoadjuvanten Therapie keine Komplettremission, bietet eine Therapie mit Trastuzumab Emtansin langfristig Vorteile: Die Sterberate ist im Vergleich zu einer Trastuzumab-Therapie um ein Drittel reduziert.

Studie zur HIFU bei Prostatakrebs lässt viele Fragen offen

Führt eine HIFU-Ablation beim Prostatakarzinom im Vergleich mit einer radikalen Prostatektomie zu ähnlichen onkologischen, aber besseren funktionalen Ergebnissen? Interimsdaten der französischen HIFI-Studie sind uneindeutig. In einem Kommentar zur Studie werden zumindest drei allgemeine Erkenntnisse herausgearbeitet.

Leitlinienkonformes Management thermischer Verletzungen

Thermische Verletzungen gehören zu den schwerwiegendsten Traumen und hinterlassen oft langfristige körperliche und psychische Spuren. Die aktuelle S2k-Leitlinie „Behandlung thermischer Verletzungen im Kindesalter (Verbrennung, Verbrühung)“ bietet eine strukturierte Übersicht über das empfohlene Vorgehen.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise